Williams Blood Cancer Research Group

Congratulations to @IrenemGhobrial, MD, recipient of Senior Researcher Prize of the Francesca Cassinelli Award for 2025. The award recognizes Ghobrial's exceptional scientific excellence, international leadership, and impactful contributions to multiple myeloma. Learn more: bit.ly/4cFHFV4

Dr. Aditi Shastri and team at @MontefioreNYC reveal that a STAT3 degrader demonstrates efficacy in venetoclax resistant acute myeloid leukemia. 📕 @LeukemiaJnl 🔖 go.nature.com/4awWJmx

Exciting fully funded PhD opportunity @UofGCancerSci @POGLRC exploring #inequalities in #clinical trials 👇 findaphd.com/phds/project/f…

A new way to tackle liver and bowel cancers has been discovered @CRUK_SI @UofGCancerSci 🔬🧫🧪bbc.co.uk/news/articles/…

It was great to see the Rare Cancers Bill pass its Second Reading in @UKHouseofLords last week. Thank you to Baroness @delythjmorgan for speaking about the poor survival rates for AML and raising the issues in leukaemia that the bill hopes to address. 🤞

Just in time for #ASH25 MRD in Myeloma: all your questions answered! How to use MRD assessment in practice and research. @ZanwarSaurabh @LeukemiaJnl For a limited time get free access through this link: nam12.safelinks.protection.outlook.com/?url=https%3A%… The principles we discuss apply for all cancers. We discuss its use as -Prognostic marker -Regulatory endpoint -Integral Biomarker to change therapy -Marker of Cure @MayoCancerCare @Myeloma_mSMART @MyelomaTeacher @mtmdphd @IMFmyeloma #IMFASH25

How can post-translational modifications rewrite cellular networks? Read communities.springernature.com/posts/how-post… @SpringerNature @TrendsBiochem #Epichaperome #PTMs #NetworkBiology #SystemsBiology #MolecularChaperones #CellBiology #Neurodegeneration #CancerResearch

I'm pleased to be a panellist @ the @CRUKresearch's upcoming children's & young people's cancers webinar: exploring the underlying biology of cancers in #TYA. Join me on 29 Sept 3-4:30 pm (BST): cruk.ink/3laVFsV #ExploringCYPCancers @UofGCancerSci @POG_LRC

Trump and his billionaire friends are ripping us off‼️ It was never about lowering the prices of anything‼️ It was always about control and power‼️

Research is never a solo effort. It takes teamwork. It takes belief. It takes collaboration across disciplines, institutions, and communities. We know what it takes to beat blood cancer. #BloodCancerAwarenessMonth @bloodcancer_uk @UofGCancerSci

Fantastic review by @GabrielaChiosis and team connecting the epichaorome with the chaperone code

In memory of Len Neckers, whose pioneering work on #HSP90 and #PTMs laid the foundation for how we think about chaperone regulation. Our latest @TrendsBiochem review builds on this legacy to explore the formation and function of #epichaperomes. doi.org/10.1016/j.tibs…

Classically activated macrophages undergo functionally significant nucleotide metabolism remodelling driven by nitric oxide go.nature.com/45khspF

Exciting and upportive opportunities below @young_eha @EHA_Hematology 👇

We are delighted to share that Lymphoma Action, in partnership with @LeukUK and @MyelomaUK, is working with the NHS England Cancer Programme on the development of a Best Practice Timed Pathway (BPTP) for blood cancers including #lymphoma. The upcoming pathway will be the...

📍 We’ve just launched our 23rd UK Hospital Hub in Belfast! 🙌 In partnership with @LAL_NI and thanks to @TNLComFundNI, LC Navigator Susanne is now on hand weekly to support leukaemia patients & families across Northern Ireland. Find out more about our Hospital Hubs here bit.ly/HospitalHubs #LeukaemiaCare #BloodCancerSupport #NorthernIreland #HospitalHub #LLNI

Changes in diagnosis, risk assessment, monitoring, and therapeutic management of AML with at least 12 approved therapies. 👍🏻 onlinelibrary.wiley.com/doi/10.1002/aj…

Grateful to @BloodCancer_Res for the funding support and the invite to talk today. Great to catch up with colleagues who are all trying to improve the lives of people affected by blood cancer #beatingbloodcancer

We have 2 exciting roles in our team: Research Engagement Officer (p/t, hybrid £31,000 - £35,000 / year) Research Grants Officer (hybrid, £35,000 - £37,000 / year) More info here 👉🏻 shorturl.at/s8jYf Please share and get in touch if you’re interested ☺️

@QUBBloodCancer @Lappin_Lab_QUB @LAL_NI @LeukUK @CR_UK Outstanding work!

Just published by @Lappin_Lab_QUB @QUBBloodCancer - BV-6 represents a therapeutic opportunity for SF3B1 mutant cancers. @LAL_NI @LeukUK @CR_UK nature.com/articles/s4141…